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Processing of neural information is thought to occur
by integration of excitatory and inhibitory synaptic in-
puts. As such, precise control mechanismsmust exist
to maintain an appropriate balance between each syn-
apse type. Recent findings indicate that neuroligins
and their synaptic binding partners modulate the de-
velopment of both excitatory and inhibitory synapses.
Here we highlight these findings and discuss a mech-
anism potentially involved in controlling the balance
between excitation and inhibition.
Excitation and inhibition in the CNS are mediated mainly
by the neurotransmitters glutamate and g-amino butyric
acid (GABA), respectively. Remarkably, neurons take
exquisite care in outfitting each synapse type with char-
acteristic structural and neurochemical features (Kim
and Sheng, 2004; Luscher and Keller, 2004). For exam-
ple, most excitatory synapses are formed through con-
tact between glutamate-releasing axonal terminals and
postsynaptic dendritic spines containing glutamate re-
ceptors. Conversely, inhibitory synapses are formed
on the dendritic shaft where GABA receptors are found
apposed to terminals positive for GABA biosynthetic
enzymes. The number of excitatory versus inhibitory
contacts that a single neuron receives dictates neuronal
excitability and function (Schummers et al., 2002). Thus,
precise control systems must be established in each
neuron to maintain appropriate numbers of excitatory
and inhibitory synapses. However, factors that trigger
the transformation of initial sites of contact to either ex-
citatory or inhibitory synapses and ultimately modulate
synaptic balance have only recently been discovered.
The first clues to understanding how excitatory syn-
apses are formed stem from exciting new studies that
identify cell adhesion molecules and scaffolding pro-
teins as regulators of contact formation and neuro-
transmitter receptor clustering. The discovery that
heterologous expression of neuroligin 1 (NLG1) or Syn-
CAM1 is sufficient to induce the recruitment of presyn-
aptic elements to contact sites was a major turning
point in understanding the direct involvement of cell ad-
hesion molecules in synaptic differentiation (Biederer
et al., 2002; Scheiffele et al., 2000). Furthermore, manip-
ulation of the expression of scaffolding proteins such as
members of the postsynaptic density protein-95 (PSD-
95) family, shank, homer, and several other molecules
clarified some of the mechanisms that modulate gluta-
mate receptor clustering and the formation of dendritic
spines (Bredt and Nicoll, 2003; Kim and Sheng, 2004).
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made in understanding how coupling of cell adhesion
molecules to their synaptic partners is involved in neu-
ronal contact formation. For instance, NLG1 has been
shown to induce clustering of its presynaptic partner,
neurexin-1b, which is in turn thought to recruit the neu-
rotransmitter release machinery (Dean et al., 2003). In
support of this, incubation with a soluble fragment of
neurexin-1b that interferes with NLG1-neurexin-1b bind-
ing blocks the effects of NLG1 on synapse formation
(Scheiffele et al., 2000). Similarly, mutations that disrupt
homophilic associations of SynCAM1 impede presyn-
aptic maturation (Biederer et al., 2002). This implies
that trans-synaptic signaling through cell adhesion mol-
ecules may play a general role in transducing synap-
togenic effects. Several other recently discovered
adhesion molecules modulate maturation of excitatory
synaptic contacts; however, unlike NLG1 and Syn-
CAM1, no evidence exists that any of these proteins
are sufficient to drive presynaptic contact formation.
Despite the major advances in uncovering factors in-
volved in the maturation of excitatory synapses, no mol-
ecules that induce inhibitorysynaptic contacts have been
reported until recently. New findings from Prange et al.
(2004) provided new insights into a novel role for neuroli-
gins in inhibitory synapse development. Unexpectedly,
overexpression of NLG1 in hippocampal neurons induces
not only excitatory synapses but also robustly enhances
the number and activity of inhibitory contacts. These re-
sults provided the first evidence that neuroligins may be
directly involved in the development of inhibitory syn-
apses. More recent studies have shown that other mem-
bers of the neuroligin family, namely, NLG2, NLG3, and
NLG4, exert similar effects on both types of synapses
(Chih et al., 2005; Graf et al., 2004; Levinson et al.,
2005). In support of an in vivo role for neuroligins in in-
hibitory synapse development, Brose and colleagues
discovered that while NLG1 is found at excitatory synap-
ses, NLG2 is localized at inhibitory postsynaptic sites
(Song et al., 1999; Varoqueaux et al., 2004). This emerg-
ing role in inhibitory synapse development seems to be
characteristic of neuroligins but not SynCAM1 (Sara
et al., 2005), pointing to a novel and specific role for neu-
roligins in the development of inhibitory synapses.
Other key findings have suggested a novel role for b-
neurexin in inhibitory synapse development. Neurexin-
1b expressed in non-neuronal cells or coupled to beads
is sufficient to induce clustering of neuroligins and var-
ious scaffolding proteins and neurotransmitter recep-
tors normally present at either excitatory or inhibitory
postsynaptic sites (Graf et al., 2004; Nam and Chen,
2005). In hippocampal neurons, inhibitory presynaptic
contact number, as well as current frequency and am-
plitude, was diminished by disruption of coupling of
neuroligins to b-neurexin (Levinson et al., 2005). These
studies suggest that interactions between b-neurexin
and neuroligins are required for pre- and postsynaptic
differentiation. It is uncertain, however, whether b-neu-
rexin is the endogenous presynaptic receptor for neuro-
ligins. Elucidation of b-neurexin localization at inhibitory
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therefore be crucial to firmly establish a role for b-neu-
rexin in inhibitory synapse formation.
A surprising new finding appearing in the current is-
sue of Neuron indicates that neuroligins can also inter-
act with a-neurexins and that this process is regulated
by alternative splicing (Boucard et al., 2005). Using a bio-
chemical approach, Su¨dhof and colleagues showed
that neuroligins lacking an insert of 8 residues at splice
site B bind to both b- and a-neurexins. Moreover, over-
expression studies showed that this splice variant had
more dramatic effects on synaptic contact size and
less pronounced effects on synapse number when
compared to the neuroligin isoform containing this in-
sert. These data therefore offer the possibility that the
properties of a given synapse may in part be dictated
by the particular combination of neuroligins and neurex-
ins present at that site. This novel role for a-neurexins
differs substantially from its previously proposed func-
tion in neurotransmitter release at excitatory and in-
hibitory synapses, which is attributed to effects of
a-neurexins on N- and P/Q-type Ca2+ channels (Missler
et al., 2003; Zhang et al., 2005). Despite this intriguing
finding, however, the physiological relevance of the pro-
posed splice code in the development of synaptic con-
tacts remains preliminary. In the future, it will be im-
portant to determine the abundance and expression
profile of individual neuroligin isoforms in neurons in
early development. Additional studies will also be re-
quired to determine whether this mechanism represents
a predominant means for regulation of specific aspects
of synapse development, including maturation and
function of excitatory and inhibitory synapses.
Evidence stemming from recent studies by Craig and
colleagues indicates that postsynaptic specificity may
be regulated by NLG1 and NLG2 through differential re-
cruitment of adaptor proteins involved in neurotransmit-
ter receptor clustering (Graf et al., 2004). In particular,
clustering of NLG2 in neurons results in coaggregation
of both PSD-95 and gephyrin, a scaffolding protein
found only at inhibitory synapses. On the other hand,
clustering of NLG1, NLG3, or NLG4 induces aggregation
of PSD-95 but not gephyrin. On a similar note, work car-
ried out by Chih et al. (2005) shows that overexpression
of NLG1 in neurons induces clustering of a number of
postsynaptic proteins found at excitatory synapses, in-
cluding PSD-95, homer, and NMDA receptors (Chih
et al., 2005). Other studies showed that neuroligin-
induced synapses contain NMDA receptor subunits
but lack active AMPA receptors, suggesting that neuro-
ligins induce the formation of silent synapses (Graf
et al., 2004; Nam and Chen, 2005). However, these
results contrast with other findings that report that
overexpression of neuroligins does not significantly
alter clustering of any postsynaptic proteins examined,
including PSD-95, as well as AMPA and NMDA receptor
subunits (Levinson et al., 2005; Prange et al., 2004). The
observed differences may simply be due to the develop-
mental stages examined or differences in neuroligin
expression levels. It therefore remains unclear whether
the trigger for stabilization of newly formed contacts is
accumulation of cell adhesion molecules or clustering
of scaffolding proteins. Despite these discrepancies,
the reported observations suggest that appropriateclustering of neuroligins and their binding partners is
critical for the development of fully functional synapses.
Based on the findings discussed so far, it appears
that b-neurexin as well as neuroligins have the inherent
ability to affect both excitatory and inhibitory syn-
apse development. If this is the case, then how might
synapse specificity be controlled by these proteins?
Mounting evidence suggests that b-neurexin may be
a presynaptic cue required to instruct which proteins
cluster in contacting dendrites. This process may be
mediated through b-neurexin-induced clustering of
neuroligins. Recruitment of specific molecules may
then regulate the type of neurotransmitter receptors re-
cruited at these sites. For instance, association of neu-
roligins with proteins such as PSD-95 may induce
assembly of a core complex containing glutamate re-
ceptors which may determine excitatory synapse iden-
tity, whereas other unidentified adaptor proteins may
recruit inhibitory neurotransmitter receptors.
However, the finding that formation of active presyn-
aptic sites precedes rapid recruitment of excitatory post-
synaptic elements implies another scenario whereby
presynaptic differentiation occurs independently of
postsynaptic mechanisms (Ziv and Garner, 2004). Cou-
pling of neuroligins to b-neurexins may then be required
for stabilization rather than formation of nascent con-
tacts. In this regard, molecules that control retention of
these cell adhesion molecules at a particular synapse
type may eventually determine the specificity of stabi-
lized synapses. In support of this, interplay between
NLG1 and its postsynaptic partner PSD-95 has been pro-
posed to restrict the influence of NLG1 to excitatory syn-
apses (Prange et al., 2004). Further studies will be re-
quired to elucidate the contribution of these proteins to
synapse formation versus stabilization. Visualization of
these molecules in live neurons may help define the tim-
ing of recruitment of these proteins to excitatory and in-
hibitory contact sites and therefore clarify this issue.
Another new paradigm that has come to light indi-
cates that differential association of neuroligins with
scaffolding proteins modulates the balance between
excitatory and inhibitory synapses. When PSD-95 and
NLG1 are coexpressed in hippocampal neurons, the ef-
fects of NLG1 on inhibitory synapses is abolished, with
a corresponding increase in NLG1 accumulation at ex-
citatory contacts (Levinson et al., 2005; Prange et al.,
2004). Another interesting finding is that enhanced
PSD-95 levels are associated with a shift in the distribu-
tion of endogenous NLG2 from inhibitory to excitatory
synapses (Levinson et al., 2005). Consistent with this,
electrophysiological recordings of PSD-95 transfected
cells show an overall increase in the ratio of excitatory
to inhibitory (E/I) synaptic currents. Conversely, RNA
knockdown of PSD-95 reduces the E/I synapse ratio
(Prange et al., 2004). These observations indicate that
relative levels of scaffolding proteins that regulate excit-
atory synapse maturation may modulate the E/I ratio by
sequestering members of the neuroligin family to excit-
atory synapses at the expense of inhibitory contacts.
The coupling of neuroligins to b-neurexin also appears
to regulate the E/I ratio. Although NLG1-dependent in-
creases in both excitatory and inhibitory currents are di-
minished by treatment with soluble b-neurexin, the
effects on inhibitory currents were more dramatic,
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currents (Levinson et al., 2005). Experiments on animals
deficient for neuroligins, neurexins, and PSD-95 will be
important to verify whether the E/I ratio is regulated by
these molecules in vivo.
Research carried out by Chih et al. (2005) lends further
support to the notion that E/I balance can be controlled
by neuroligins. In this set of experiments, an RNA inter-
ference-mediated approach was used to knock down
endogenous levels of NLG1-3, resulting in a consider-
able reduction in the number of both excitatory and
inhibitory synapses. When examining the electrophysio-
logical correlates of these effects, it was noted that
knockdown of neuroligins translates mainly into a reduc-
tion in inhibitory synaptic transmission, thus altering the
balance between excitation and inhibition. However, it
remains unclear why knockdown of individual neuroligin
family members has the same effect on synapse num-
ber as loss of NLG1-3 combined. One possibility is
that compensatory mechanisms contributed to damp-
ening the effects of the loss of neuroligins. Alternatively,
the synaptogenic effects seen upon manipulation of the
expression of these molecules may simply be due to
homeostatic changes that occur secondary to altered
synapse function, rather than changes in synapse for-
mation per se. However, the ability of these molecules
to robustly induce the formation of heterogeneous
types of contacts before the development of functional
synapses argues against this. Despite these caveats,
the findings discussed here provide intriguing new in-
sights into the role of these proteins in synaptic devel-
opment and control of E/I ratio (Figure 1).
Thus, a new concept emerges, whereby stoichiome-
try between adhesion molecules and scaffolding pro-
teins regulates their targeting to and/or retention at
contact sites, thereby dictating the number of excitatory
and inhibitory synapses. One key characteristic of this
model is the implication that scaffolding molecules
may cooperate or compete with one another to affect
the ultimate targeting of cell adhesion molecules, thus
creating a ‘‘tug of war’’ situation. The outcome of such
competitive interactions may be determined by differ-
ential affinities of postsynaptic scaffolding proteins for
certain adhesion molecules. Furthermore, scaffolding
proteins present at presynaptic terminals, such as Bas-
soon and Piccolo, may indirectly cooperate with post-
synaptic elements to stabilize one particular type of
synapse (Ziv and Garner, 2004). Finally, crosstalk be-
tween different sets of adhesion molecules implicated
in development of inhibitory synapses, which include
the neural CAM, L1, L-CAM, and dystroglycans, may
also modulate the actions of other proteins at nascent
contact sites and control synaptic specificity (Brunig
et al., 2002; Levi et al., 2002; Saghatelyan et al., 2004).
Next, it will be important to determine how endoge-
nous NLG2 preferentially accumulates at inhibitory syn-
apses. In addition to PDZ-dependent interactions, the
C-terminal domain of each of the neuroligins may asso-
ciate with other specific elements that cooperate or com-
pete with PSD-95 for targeting of neuroligins to excit-
atory or inhibitory synapses. Further work is required to
determine whether this process involves competition
between PDZ-containing proteins and molecules such
as gephyrin or GABA receptor interacting proteins toregulate NLG2 accumulation at inhibitory synapses (Lus-
cher and Keller, 2004). Most likely, the collective actions
of all of these proteins control differential localization of
adhesion molecules involved in synapse development.
In the adult brain, a similar paradigm may exist
whereby regulated retention or removal of certain adhe-
sion molecules at particular synaptic sites results in
weakening or strengthening of either excitatory or
inhibitory synaptic activity and in turn modulates E/I
Figure 1. New Players Implicated in the Control of Excitatory to
Inhibitory Synaptic Ratio
(A) Cell adhesion molecules such as neuroligin 1 (NLG1) and NLG2
induce excitatory and inhibitory synapses. NLG1 is enriched at ex-
citatory sites, whereas NLG2 is concentrated at inhibitory sites.
Neuroligins associate with the scaffolding protein PSD-95, which
is exclusively localized at excitatory sites. Interaction with PSD-
95 enhances NLG1 accumulation at excitatory synapses. Other un-
identified scaffolding proteins sequester NLG2 at inhibitory synap-
ses. The relative levels of these proteins ensure an appropriate ratio
of excitatory to inhibitory (E/I) synaptic input received by individual
neurons during early development. (B–D) Altered expression of
neuroligins or PSD-95 manipulates the E/I ratio. (B) Loss of neuro-
ligins hinders maturation of both excitatory and inhibitory synap-
ses. Redundancy of cell adhesion molecules present at excitatory
sites may compensate for loss of neuroligins and result in a less
dramatic effect as compared to inhibitory synapses, where few
such proteins have been implicated. Loss of neuroligins will also re-
duce b-neurexin clustering at presynaptic terminals. This results in
an overall enhanced E/I ratio. (C) Enhanced levels of PSD-95 aug-
ment NLG1 clustering at excitatory synapses and redistribute
NLG2 to excitatory sites. This results in an enhancement of excit-
atory presynaptic terminals and a reduction in the number of inhib-
itory contacts, thus shifting the E/I synaptic ratio toward higher
overall excitation. (D) This model predicts that loss of PSD-95 will
result in redistribution of neuroligins from excitatory synapses to in-
hibitory sites. As such, a higher number of inhibitory synapses are
formed, with a reduction in excitatory synapse formation. The over-
all effect in this situation is a decrease in the E/I ratio, leading to
lower levels of excitatory synaptic transmission.
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iological conditions have been reported. For instance,
synaptic activity upregulates PSD-95 expression
through activation of a neuregulin-mediated pathway
(Bao et al., 2004). In addition, prolonged changes in neu-
ronal activity modulate PSD-95 clustering and degrada-
tion at the synapse (Bredt and Nicoll, 2003). Expression
of PSD-95 is also subject to modulation by the Fragile X
syndrome associated protein FMRP, indicating that al-
tered PSD-95 expression may be associated with cer-
tain disease states (Todd et al., 2003). Further ex-
periments are needed to investigate in more detail
physiological paradigms that regulate the expression
levels of PSD-95, neuroligins, and other molecules im-
plicated in synaptic development and whether these
paradigms contribute to changes in E/I ratio.
These newly discovered mechanisms have important
implications in neurodevelopmental psychiatric disor-
ders such as autism and some forms of mental retarda-
tion in which an imbalance in E/I ratio is thought to occur
(Rubenstein and Merzenich, 2003). In particular, it has
been proposed that enhanced excitability associated
with autism underlies the expression of abnormal social
behavior characteristic of this disorder. The detection of
mutations in the NLG3 and NLG4 genes in some cases
of autism supports this notion. Despite the attractive
links that have been made here, however, some studies
indicate that NLG3 and NLG4 are also expressed in glia
and regions outside the brain (Bolliger et al., 2001; Gil-
bert et al., 2001). Detailed analysis of the expression
patterns of individual members of the neuroligin family
and assessment of changes in the number of excitatory
and inhibitory synapses in animals deficient for these
proteins may help clarify the involvement of these pro-
teins in psychiatric disorders.
In conclusion, the intriguing new evidence reviewed
here reveals a potential mechanism that controls devel-
opment of excitatory and inhibitory synapses as well as
an appropriate balance between these synapse types.
Homeostatic feedback mechanisms are believed to
govern these regulatory systems; however, the molecu-
lar machinery involved in these processes is only now
beginning to be elucidated (Turrigiano and Nelson,
2004). The new findings discussed here indicate that
molecular interactions, governed by specific protein
sorting and/or stoichiometry, control the balance be-
tween different synapse types. Delivery of a preassem-
bled transport protein complex containing particular
cell adhesion molecules and scaffolding proteins may
be involved in the rapid differentiation of newly formed
contact sites to either excitatory or inhibitory synapses.
To further understand how E/I synapse balance is es-
tablished and maintained, it will be essential to address
other issues. For instance, does synaptic activity con-
trol the stabilization of newly formed contact sites?
Also, at what developmental stage do neuroligins in par-
ticular come into play? It may be the case that neuro-
ligins are the cue for recruitment of presynaptic
machinery which is common to both types of synapses.
Additional pre- or postsynaptic cues at later develop-
mental stages would then be required for specification
of synapse type. Alternatively, neuroligins may only be
required for synaptic stabilization, with other factors ini-
tially determining synaptic specificity. What compen-satory mechanisms may exist to fine tune synaptic
balance, and how might these mechanisms be ex-
ploited to repair synaptic imbalance associated with
psychiatric disorders? Further manipulation of proteins
critical for building synapses will provide additional in-
sight into how the number of excitatory and inhibitory
synapses is controlled. Although these and many other
questions remain, the impressive amount of progress
recently made in this field indicates that we have now
tipped the scales in our understanding of the processes
involved in controlling synaptic balance.
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